Octreotide Alternatives Compared
| Octreotide | Sandostatin (octreotide) | Sandostatin LAR Depot (octreotide) |
|
|---|
| Octreotide | Sandostatin (octreotide) | Sandostatin LAR Depot (octreotide) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Carcinoid Tumor, Acromegaly, Diarrhea, Diabetes - Type 1, Dumping Syndrome, Gastrinoma, Glucagonoma, Insulinoma, Pituitary Adenoma, Postural Orthostatic Tachycardia Syndrome, Small... View more |
Prescription only
Prescribed for Carcinoid Tumor, Acromegaly, Vasoactive Intestinal Peptide Tumor. Sandostatin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Carcinoid Tumor, Acromegaly, Vasoactive Intestinal Peptide Tumor. Sandostatin LAR Depot may also be used for purposes not listed in this medication guide. |
Related suggestions Carcinoid Tumor
Vasoactive Intestinal Peptide Tumor
Popular comparisons
|
|||||||||||||||||||||||
| More about Octreotide | More about Sandostatin (octreotide) | More about Sandostatin LAR Depot (octreotide) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Octreotide has an average rating of 7.7 out of 10 from a total of 18 ratings on Drugs.com. 72% of reviewers reported a positive effect, while 11% reported a negative effect. |
Sandostatin has an average rating of 8.0 out of 10 from a total of 7 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 0% reported a negative effect. |
Sandostatin LAR Depot has an average rating of 8.7 out of 10 from a total of 7 ratings on Drugs.com. 86% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Octreotide side effects |
View all Sandostatin side effects |
View all Sandostatin LAR Depot side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic approved | |||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Octreotide prices |
View all Sandostatin prices |
View all Sandostatin LAR Depot prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Bynfezia Pen, Mycapssa, Sandostatin, Sandostatin LAR Depot | Other octreotide brands include: Bynfezia Pen, Mycapssa, Sandostatin LAR Depot | Other octreotide brands include: Bynfezia Pen, Mycapssa, Sandostatin | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
1.5 hours |
1.5 hours |
1.5 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 166 drugs are known to interact with Octreotide:
|
A total of 166 drugs are known to interact with Sandostatin:
|
A total of 166 drugs are known to interact with Sandostatin LAR Depot:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
June 26, 2020 |
October 21, 1988 |
N/A |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Sandostatin
Sandostatin is used to treat acromegaly and to reduce flushing episodes and watery diarrhea caused ...
Parlodel
Parlodel is used for acromegaly, hyperprolactinemia, parkinson's disease
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Somatuline Depot
Somatuline Depot is used as a long-term treatment for acromegaly. Learn about side effects ...
Sandostatin LAR Depot
Sandostatin LAR Depot is used for acromegaly, carcinoid tumor, vasoactive intestinal peptide tumor
Signifor
Signifor (pasireotide) is a man-made protein that is similar to somatostatin and is used to treat ...
Cycloset
Cycloset is used to treat Type 2 Diabetes. Learn about side effects, interactions and indications.
Mycapssa
Mycapssa (octreotide) is used for the treatment of acromegaly. Includes Mycapssa side effects ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.